FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2040895967> ?p ?o ?g. }

• W2040895967 endingPage "1865" @default.
• W2040895967 startingPage "1859" @default.
• W2040895967 abstract "It has been reported that approximately one-third of patients undergoing cardiovascular surgery experience paroxysmal atrial fibrillation (AF) during the postoperative period. There is, however, little information on the selection of anti-arrhythmic drugs for terminating postoperative paroxysmal AF.Between April 2007 and March 2009, 118 patients (76 men, 42 women, mean age 68+/-10 years) who had postoperative paroxysmal AF lasting > or =30 min were randomly assigned to receive either iv cibenzoline (70 mg, n=60) or disopyramide (50 mg, n=58) for terminating postoperative paroxysmal AF. The success rate of iv cibenzoline therapy (47%) was significantly greater than that of iv disopyramide therapy (24%; P<0.05). To identify clinical factors to increase the termination efficacy of iv cibenzoline, multivariate logistic regression was used to adjust for several covariates and to generate adjusted odds ratios (OR). The significant variables for the termination of paroxysmal AF after iv cibenzoline therapy were pretreatment with oral beta-adrenergic blockers (OR =8.224, P=0.030) and smaller left atrial dimensions (OR =0.879, P=0.039).The efficacy of iv cibenzoline for the termination of postoperative paroxysmal AF was significantly better than that of disopyramide, especially in patients with pre-administration of oral beta-adrenergic blockers and those with smaller left atrium." @default.
• W2040895967 created "2016-06-24" @default.
• W2040895967 creator A5004953300 @default.
• W2040895967 creator A5029014346 @default.
• W2040895967 creator A5044892880 @default.
• W2040895967 creator A5049735703 @default.
• W2040895967 creator A5067050298 @default.
• W2040895967 creator A5080715331 @default.
• W2040895967 creator A5081749381 @default.
• W2040895967 creator A5086380697 @default.
• W2040895967 date "2010-01-01" @default.
• W2040895967 modified "2023-10-16" @default.
• W2040895967 title "Prospective Comparative Study of Intravenous Cibenzoline and Disopyramide Therapy in the Treatment of Paroxysmal Atrial Fibrillation After Cardiovascular Surgery" @default.
• W2040895967 cites W1482820024 @default.
• W2040895967 cites W1966010228 @default.
• W2040895967 cites W1967701161 @default.
• W2040895967 cites W1972293028 @default.
• W2040895967 cites W1978024211 @default.
• W2040895967 cites W1978597867 @default.
• W2040895967 cites W1987662971 @default.
• W2040895967 cites W1990240357 @default.
• W2040895967 cites W1998670507 @default.
• W2040895967 cites W1999199829 @default.
• W2040895967 cites W2001426264 @default.
• W2040895967 cites W2003405162 @default.
• W2040895967 cites W2010550566 @default.
• W2040895967 cites W2014707446 @default.
• W2040895967 cites W2016659665 @default.
• W2040895967 cites W2016962943 @default.
• W2040895967 cites W2032007963 @default.
• W2040895967 cites W2037002517 @default.
• W2040895967 cites W2038093356 @default.
• W2040895967 cites W2039896484 @default.
• W2040895967 cites W2052154644 @default.
• W2040895967 cites W2059498796 @default.
• W2040895967 cites W2064897980 @default.
• W2040895967 cites W2065339616 @default.
• W2040895967 cites W2072162333 @default.
• W2040895967 cites W2077151900 @default.
• W2040895967 cites W2078856783 @default.
• W2040895967 cites W2081497884 @default.
• W2040895967 cites W2087431627 @default.
• W2040895967 cites W2099830583 @default.
• W2040895967 cites W2109029322 @default.
• W2040895967 cites W2126567445 @default.
• W2040895967 cites W2141077974 @default.
• W2040895967 cites W2463417997 @default.
• W2040895967 cites W2517864976 @default.
• W2040895967 cites W3081500081 @default.
• W2040895967 doi "https://doi.org/10.1253/circj.cj-10-0023" @default.
• W2040895967 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20631453" @default.
• W2040895967 hasPublicationYear "2010" @default.
• W2040895967 type Work @default.
• W2040895967 sameAs 2040895967 @default.
• W2040895967 citedByCount "4" @default.
• W2040895967 countsByYear W20408959672012 @default.
• W2040895967 countsByYear W20408959672016 @default.
• W2040895967 countsByYear W20408959672019 @default.
• W2040895967 crossrefType "journal-article" @default.
• W2040895967 hasAuthorship W2040895967A5004953300 @default.
• W2040895967 hasAuthorship W2040895967A5029014346 @default.
• W2040895967 hasAuthorship W2040895967A5044892880 @default.
• W2040895967 hasAuthorship W2040895967A5049735703 @default.
• W2040895967 hasAuthorship W2040895967A5067050298 @default.
• W2040895967 hasAuthorship W2040895967A5080715331 @default.
• W2040895967 hasAuthorship W2040895967A5081749381 @default.
• W2040895967 hasAuthorship W2040895967A5086380697 @default.
• W2040895967 hasBestOaLocation W20408959671 @default.
• W2040895967 hasConcept C126322002 @default.
• W2040895967 hasConcept C156957248 @default.
• W2040895967 hasConcept C164705383 @default.
• W2040895967 hasConcept C2778131192 @default.
• W2040895967 hasConcept C2779161974 @default.
• W2040895967 hasConcept C2779831137 @default.
• W2040895967 hasConcept C2780074459 @default.
• W2040895967 hasConcept C42219234 @default.
• W2040895967 hasConcept C71924100 @default.
• W2040895967 hasConceptScore W2040895967C126322002 @default.
• W2040895967 hasConceptScore W2040895967C156957248 @default.
• W2040895967 hasConceptScore W2040895967C164705383 @default.
• W2040895967 hasConceptScore W2040895967C2778131192 @default.
• W2040895967 hasConceptScore W2040895967C2779161974 @default.
• W2040895967 hasConceptScore W2040895967C2779831137 @default.
• W2040895967 hasConceptScore W2040895967C2780074459 @default.
• W2040895967 hasConceptScore W2040895967C42219234 @default.
• W2040895967 hasConceptScore W2040895967C71924100 @default.
• W2040895967 hasIssue "9" @default.
• W2040895967 hasLocation W20408959671 @default.
• W2040895967 hasLocation W20408959672 @default.
• W2040895967 hasOpenAccess W2040895967 @default.
• W2040895967 hasPrimaryLocation W20408959671 @default.
• W2040895967 hasRelatedWork W1967841144 @default.
• W2040895967 hasRelatedWork W2018480046 @default.
• W2040895967 hasRelatedWork W2064495796 @default.
• W2040895967 hasRelatedWork W2319489406 @default.
• W2040895967 hasRelatedWork W2333279585 @default.
• W2040895967 hasRelatedWork W2600182461 @default.
• W2040895967 hasRelatedWork W2603808924 @default.

• next